Altria reported a mixed first half of 2025, with overall declines tempered by the strong performance of its oral tobacco products segment – a substantial driver of growth in the second quarter.
During the presentation of its first-half results, the company said its net revenue decreased slightly by 3.6% to $11.4bn in the first six months of 2025, driven by lower net revenues in the smokeable products segment. In the second quarter, the company’s revenue fell by 1.7% to $6.1bn. However, revenue in the oral tobacco segment increased by 3.3% and 5.9% in the first half of the year and second quarter, respectively.
